BIONOTE
LIVE

Serial Number

88680678

Owner

EVEREST CLINICAL RESEARCH CORPORATION

Attorney

Camille M. Miller

First Use Date

Nov 1, 2020

Filing Date

Nov 5, 2019

Add to watchlist:

No watchlists yet
View on USPTO

BIONOTE Trademark

Serial Number: 88680678 • Registration: 6555859

BIONOTE is a trademark filed by EVEREST CLINICAL RESEARCH CORPORATION on November 5, 2019. The trademark is classified under Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

EVEREST CLINICAL RESEARCH CORPORATION (6 trademarks)

675 COCHRANE DRIVE EAST TOWER, 4TH FLOOR
Ontario L3R0B8 , CA

Entity Type: 03

Trademark Details

Filing Date

November 5, 2019

Registration Date

November 9, 2021

First Use Anywhere

November 1, 2020

First Use in Commerce

November 1, 2020

Published for Opposition

April 7, 2020

Goods & Services

Downloadable computer software for capturing, reporting, and processing of data in pharmaceutical industry clinical trials; recorded computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient-reported outcomes in pharmaceutical industry clinical trials; recorded computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient-reported outcomes in pharmaceutical industry clinical trials on handhelds and PDAs; downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient-reported outcomes in pharmaceutical industry clinical trials; downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient-reported outcomes in pharmaceutical industry clinical trials on handhelds and PDAs; downloadable mobile applications for generating patient-reported outcome reports in pharmaceutical industry clinical trials; downloadable software for enabling patients to select a medication from a list of their frequent medications, select a new drug or therapy, and enter all medication intake, and for adding the aforementioned information to existing study questionnaires as a way to record concomitant medications

Filing History

REGISTERED-PRINCIPAL REGISTER
Nov 9, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 6, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 5, 2021 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 17, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 17, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 17, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 10, 2021 GNFN
FINAL REFUSAL E-MAILED
Aug 10, 2021 GNFR
SU - FINAL REFUSAL - WRITTEN
Aug 10, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 12, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 12, 2021 CRFA
ASSIGNED TO LIE
Jul 9, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 26, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 24, 2021 GNRN
NON-FINAL ACTION E-MAILED
Feb 24, 2021 GNRT
SU - NON-FINAL ACTION - WRITTEN
Feb 24, 2021 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Feb 3, 2021 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 2, 2021 AITU
USE AMENDMENT FILED
Jan 13, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 13, 2021 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 11, 2020 EXRA
SOU EXTENSION 1 GRANTED
Nov 9, 2020 EX1G
SOU EXTENSION 1 FILED
Nov 9, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 9, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 2, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 18, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 3, 2020 CNSA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 15, 2020 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 15, 2020 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 15, 2020 COAR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 15, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 15, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 15, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 14, 2020 GNRN
NON-FINAL ACTION E-MAILED
Feb 14, 2020 GNRT
NON-FINAL ACTION WRITTEN
Feb 14, 2020 CNRT
ASSIGNED TO EXAMINER
Feb 10, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 13, 2019 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 12, 2019 NWOS
NEW APPLICATION ENTERED
Nov 8, 2019 NWAP